Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
about
START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus InfectionMetabolic syndrome, diabetes, and cardiovascular risk in HIVIncomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutionsEffect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in miceLevels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patientsIncidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda.Effects of aging and smoking on carotid intima-media thickness in HIV-infection.Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events ofHepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.NOS1 methylation and carotid artery intima-media thickness in children.Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activationInitiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Impact of HIV infection on diastolic function and left ventricular mass.Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study.Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patientsThe consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.Adipokines and vascular health in treated HIV infection: an obesity paradox?Associations between HIV infection and subclinical coronary atherosclerosisApproach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosisAssociation between human immunodeficiency virus infection and stiffness of the common carotid artery.T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHSHIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort studyAssociation of immunologic and virologic factors with myocardial infarction rates in a US healthcare system.Immunologic basis of cardiovascular disease in HIV-infected adults.T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.Silent ischemic heart disease and pericardial fat volume in HIV-infected patients: a case-control myocardial perfusion scintigraphy study.Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, TanzaniaT cell activation predicts carotid artery stiffness among HIV-infected womenEcholucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.Effect of inter-reader variability on outcomes in studies using carotid intima media thickness quantified by carotid ultrasonographyMetabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study
P2860
Q26753830-F96BDF8E-03AD-4EC7-A58E-4BFC88F86435Q26853470-13128583-A814-462E-BFBC-1D21B3667DFBQ27021524-F42DFD76-CE20-48B9-BF65-C676541E7700Q28513259-DC8CB8BB-58C2-4202-85D3-5EA8E6BD3A8CQ28728667-A9E5FC09-D121-45D7-9A6B-3DE2E783DC82Q30278586-8FB1B493-45B8-46B3-89AA-94AA6CB9448FQ30540864-317CC7EC-DF09-4A7E-A640-EF9C17D5ED75Q30593046-58257A43-8E2A-47D7-97B7-2859F0B47370Q30934548-4E1A7001-D7DD-477B-A8B2-94378E653497Q30987054-D7F6B6D0-CE64-4B61-934C-21AD87ACC442Q31115875-F56ACD18-E718-4FE7-B85E-156162EABDA0Q33561529-65C02067-BEC0-4F3B-9FE1-F0B2019C689EQ33597485-A08497DF-E904-4D64-ADFB-CD29C6648869Q33649200-C63F2728-9621-4A37-920D-F64534B11771Q33721647-DFADA073-057C-4B3B-ADCA-3A956B794A09Q33761167-74363238-945E-42AE-8A97-173DF4745EC4Q33864945-BBC9CD0C-7D10-41CB-A181-151EDA34606DQ33889580-101C4D22-2C86-4B37-BBD7-991796E6500FQ33987654-21BF3107-4F14-4A89-B13F-E7F62576A428Q33991362-8FB86AD1-D752-4C32-A85B-776DB6ABFC62Q34075808-9339A612-D4B6-499F-BBAB-093A6148AAD2Q34085805-893D125A-04A6-4E97-B552-F4DC40B98AEFQ34156361-D975760D-F063-481C-9D74-830C537A4B38Q34217096-9851FF35-B078-493E-BBCB-C413527096D4Q34275856-C4CA0F03-7224-47D5-80EE-835AEF8FBDC2Q34342183-407A9BFF-A217-498A-BB91-80E2D1F2146EQ34355660-47BD0D9B-91E4-4C2D-AA82-86EE09F65624Q34553819-E08F7355-09F9-4EA7-9E76-5A303F580984Q34563289-B01CA4D9-7013-4708-B90E-FDDBF86CBFB2Q34564981-E81688EE-ACBF-4837-B04F-8D99F2436EC2Q34638205-D27DFD7F-0DF1-47E0-95F9-94B86545D5A8Q34764361-93BEBF48-E8E1-4F49-9A23-C336699C5405Q34764372-EA754FA3-8498-4FC4-A3C3-98F3DF97093BQ34964855-C1FFF314-158B-4CC0-926C-66D86252167FQ35074678-F82C3CA2-F073-4EA2-AFF4-E5F29C666F78Q35113323-9AECB18E-A8CC-45FD-A4B8-3FE1AFDE6E7DQ35135692-CEB66F5F-4470-453E-80E5-E5BD2D6591EFQ35166149-05997875-2F72-4E3D-8518-4E0A2C75B6AFQ35179406-16A06D9B-C915-442A-89D3-77E31A0997B0Q35185674-C56D6785-C7EE-4C3D-AAC3-2959CDDFF322
P2860
Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@en
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@nl
type
label
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@en
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@nl
prefLabel
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@en
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@nl
P2093
P2860
P921
P1433
P1476
Low CD4+ T-cell count as a maj ...... in HIV-infected women and men.
@en
P2093
A Richey Sharrett
Howard N Hodis
Jason Lazar
Kathryn Anastos
Lisa P Jacobson
Lorie Benning
Phyllis C Tien
Robert C Kaplan
P2860
P304
P356
10.1097/QAD.0B013E328300581D
P407
P577
2008-08-01T00:00:00Z